{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:37:11Z","timestamp":1791193031376,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T00:00:00Z","timestamp":1420416000000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Grant-in-Aid for Young Scientists (B)","award":["24790169"],"award-info":[{"award-number":["24790169"]}]},{"name":"Grants-in-Aid for Scientific Research (A)","award":["24241043"],"award-info":[{"award-number":["24241043"]}]},{"name":"(C)","award":["23590550"],"award-info":[{"award-number":["23590550"]}]},{"DOI":"10.13039\/501100004051","name":"Kato Memorial Bioscience Foundation, Japan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004051","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009337","name":"Saitama Medical University","doi-asserted-by":"crossref","award":["22-1-2-03"],"award-info":[{"award-number":["22-1-2-03"]}],"id":[{"id":"10.13039\/501100009337","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.virol.2013.10.010","type":"journal-article","created":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T11:37:17Z","timestamp":1382701037000},"page":"159-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants"],"prefix":"10.1016","volume":"448","author":[{"given":"Masaaki","family":"Kawano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuma","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Akatsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2013.10.010_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.292.5514.69","article-title":"Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine","volume":"292","author":"Amara","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.virol.2013.10.010_bib2","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1073\/pnas.96.8.4512","article-title":"Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity","volume":"96","author":"Belyakov","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.virol.2013.10.010_bib3","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1016\/j.febslet.2005.10.062","article-title":"Polyomavirus EGFP-pseudocapsids: analysis of model particles for introduction of proteins and peptides into mammalian cells","volume":"579","author":"Boura","year":"2005","journal-title":"FEBS Letters"},{"key":"10.1016\/j.virol.2013.10.010_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0166-3542(02)00004-9","article-title":"Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb\/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A","volume":"54","author":"Buonaguro","year":"2002","journal-title":"Antiviral Research"},{"key":"10.1016\/j.virol.2013.10.010_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jnci\/91.2.119","article-title":"Cell and molecular biology of simian virus 40: implications for human infections and disease","volume":"91","author":"Butel","year":"1999","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.virol.2013.10.010_bib6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1128\/JVI.01927-09","article-title":"Papillomavirus prophylactic vaccines: established successes, new approaches","volume":"84","author":"Campo","year":"2010","journal-title":"Journal of Virology"},{"key":"10.1016\/j.virol.2013.10.010_bib7","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/hep.22816","article-title":"Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma","volume":"49","author":"Ding","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2013.10.010_bib8","doi-asserted-by":"crossref","first-page":"e23828","DOI":"10.1371\/journal.pone.0023828","article-title":"Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB\/c mice from outgrowth of a PSA expressing tumor","volume":"6","author":"Eriksson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2013.10.010_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ncb1999","article-title":"GM1 structure determines SV40-induced membrane invagination and infection","volume":"12","author":"Ewers","year":"2010","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.virol.2013.10.010_bib10","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/JVI.73.5.4465-4469.1999","article-title":"Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies","volume":"73","author":"Goldmann","year":"1999","journal-title":"Journal of Virology"},{"key":"10.1016\/j.virol.2013.10.010_bib11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/326881a0","article-title":"Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2","volume":"326","author":"Gotch","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.virol.2013.10.010_bib12","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1073\/pnas.95.4.1800","article-title":"Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model","volume":"95","author":"Greenstone","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.virol.2013.10.010_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/erv.09.163","article-title":"Norwalk virus-like particles as vaccines","volume":"9","author":"Herbst-Kralovetz","year":"2010","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/j.virol.2013.10.010_bib14","first-page":"183","article-title":"Discovery of simian virus 40 (SV40) and its relationship to poliomyelitis virus vaccines","volume":"94","author":"Hilleman","year":"1998","journal-title":"Developments in Biological Standardization"},{"key":"10.1016\/j.virol.2013.10.010_bib15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nature04081","article-title":"Prospects for a vaccine against the hepatitis C virus","volume":"436","author":"Houghton","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.virol.2013.10.010_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jbiotec.2007.12.006","article-title":"Engineering of SV40-based nano-capsules for delivery of heterologous proteins as fusions with the monor capsid proteins VP2\/3","volume":"134","author":"Inoue","year":"2008","journal-title":"Journal of Biotechnology"},{"key":"10.1016\/j.virol.2013.10.010_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1128\/JVI.75.1.61-72.2001","article-title":"Roles of disulfide linkage and calcium ion-mediated interactions in assembly and disassembly of virus-like particles composed of simian virus 40 VP1 capsid protein","volume":"75","author":"Ishizu","year":"2001","journal-title":"Journal of Virology"},{"key":"10.1016\/j.virol.2013.10.010_bib18","doi-asserted-by":"crossref","first-page":"e4667","DOI":"10.1371\/journal.pone.0004667","article-title":"Induction of long-term protective immune responses by influenza H5N1 virus-like particles","volume":"4","author":"Kang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2013.10.010_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1586\/erv.12.149","article-title":"SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier","volume":"12","author":"Kawano","year":"2013","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/j.virol.2013.10.010_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0304-4165(95)00184-0","article-title":"Purification and characterization of virus-like particles and pentamers produced by the expression of SV40 capsid proteins in insect cells","volume":"1290","author":"Kosukegawa","year":"1996","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.virol.2013.10.010_bib21","doi-asserted-by":"crossref","first-page":"a007252","DOI":"10.1101\/cshperspect.a007252","article-title":"Vaccine design for CD8 T lymphocyte responses","volume":"1","author":"Koup","year":"2011","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/j.virol.2013.10.010_bib22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/JVI.01811-07","article-title":"Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation","volume":"82","author":"Lacasse","year":"2008","journal-title":"Journal of Virology"},{"key":"10.1016\/j.virol.2013.10.010_bib23","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.4049\/jimmunol.166.9.5346","article-title":"Papillomavirus-like particles induce acute activation of dendritic cells","volume":"166","author":"Lenz","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.virol.2013.10.010_bib24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.immuni.2010.10.004","article-title":"Immunologic basis of vaccine vectors","volume":"33","author":"Liu","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.virol.2013.10.010_bib25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/viro.2000.0435","article-title":"Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes","volume":"273","author":"Liu","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.virol.2013.10.010_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/j.virol.2013.10.010_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.virol.2013.10.010_bib28","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.bbrc.2009.12.100","article-title":"A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A\u204e0201 transgenic mice","volume":"391","author":"Matsui","year":"2010","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.virol.2013.10.010_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0264-410X(02)00460-7","article-title":"Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus","volume":"21","author":"Matsui","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2013.10.010_bib30","doi-asserted-by":"crossref","first-page":"12798","DOI":"10.1128\/JVI.79.20.12798-12806.2005","article-title":"T-bet is required for protection against vaccinia virus infection","volume":"79","author":"Matsui","year":"2005","journal-title":"Journal of Virology"},{"key":"10.1016\/j.virol.2013.10.010_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.virusres.2011.08.003","article-title":"Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope","volume":"163","author":"Mazeike","year":"2012","journal-title":"Virus Research"},{"key":"10.1016\/j.virol.2013.10.010_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: clues for vaccine development","volume":"10","author":"McMichael","year":"2010","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.virol.2013.10.010_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature03290","article-title":"Cross-presentation by intercellular peptide transfer through gap junctions","volume":"434","author":"Neijssen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.virol.2013.10.010_bib34","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 \u2013 an innately attractive adjuvant formulation","volume":"30","author":"O'Hagan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2013.10.010_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.coi.2008.04.009","article-title":"WT1 peptide vaccine for the treatment of cancer","volume":"20","author":"Oka","year":"2008","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.virol.2013.10.010_bib36","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1084\/jem.185.12.2043","article-title":"HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice","volume":"185","author":"Pascolo","year":"1997","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.virol.2013.10.010_bib37","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00262-010-0895-0","article-title":"Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles","volume":"59","author":"Pejawar-Gaddy","year":"2010","journal-title":"Cancer Immunology and Immunotherapy"},{"key":"10.1016\/j.virol.2013.10.010_bib38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/ers.11.51","article-title":"Simian virus 40 transformation, malignant mesothelioma and brain tumors","volume":"5","author":"Qi","year":"2011","journal-title":"Expert Review of Respiratory Medicine"},{"key":"10.1016\/j.virol.2013.10.010_bib39","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/ijc.21781","article-title":"Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice","volume":"118","author":"Qian","year":"2006","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.virol.2013.10.010_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4161\/hv.4.1.5559","article-title":"Virus-like particles as a vaccine delivery system: myths and facts","volume":"4","author":"Roy","year":"2008","journal-title":"Human Vaccines"},{"key":"10.1016\/j.virol.2013.10.010_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0042-6822(02)00134-4","article-title":"Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope","volume":"309","author":"Sadeyen","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.virol.2013.10.010_bib42","first-page":"873","article-title":"Cytotoxic T lymphocytes from HLA-A2.1 transgenic mice define a potential human epitope from simian virus 40 large T antigen","volume":"61","author":"Schell","year":"2001","journal-title":"Cancer Research"},{"key":"10.1016\/j.virol.2013.10.010_bib43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.55.091902.104344","article-title":"Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors","volume":"55","author":"Shiver","year":"2004","journal-title":"Annual Review of Medicine"},{"key":"10.1016\/j.virol.2013.10.010_bib44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrmicro1419","article-title":"Advances in tuberculosis vaccine strategies","volume":"4","author":"Skeiky","year":"2006","journal-title":"Nature Reviews Microbiology"},{"key":"10.1016\/j.virol.2013.10.010_bib45","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.4049\/jimmunol.172.3.1777","article-title":"Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects","volume":"172","author":"Storni","year":"2004","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.virol.2013.10.010_bib46","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.antiviral.2011.06.008","article-title":"The route of immunization with adenoviral vaccine influences the recruitment of cytotoxic T lymphocytes in the lung that provide potent protection from influenza A virus","volume":"91","author":"Suda","year":"2011","journal-title":"Antiviral Research"},{"key":"10.1016\/j.virol.2013.10.010_bib47","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1128\/JVI.00783-12","article-title":"Circumventing antivector immunity by using adenovirus-infected blood cells for repeated application of adenovirus-vectored vaccines: proof of concept in rhesus macaques","volume":"86","author":"Sun","year":"2012","journal-title":"Journal of Virology"},{"key":"10.1016\/j.virol.2013.10.010_bib48","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.virol.2013.10.010_bib49","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jbiotec.2008.05.012","article-title":"Presentation of functional foreign peptides on the surface of SV40 virus-like particles","volume":"135","author":"Takahashi","year":"2008","journal-title":"Journal of Biotechnology"},{"key":"10.1016\/j.virol.2013.10.010_bib50","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00262-007-0281-8","article-title":"Dendritic cells loaded with polyomavirus VP1\/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2\/neu expressing tumor","volume":"56","author":"Tegerstedt","year":"2007","journal-title":"Cancer Immunology and Immunotherapy"},{"key":"10.1016\/j.virol.2013.10.010_bib51","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1158\/0008-5472.CAN-05-0335","article-title":"A single vaccination with polyomavirus VP1\/VP2Her2 virus-like particles prevents outgrowth of HER-2\/neu-expressing tumors","volume":"65","author":"Tegerstedt","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/j.virol.2013.10.010_bib52","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1093\/emboj\/cdg439","article-title":"Gangliosides are receptors for murine polyoma virus and SV40","volume":"22","author":"Tsai","year":"2003","journal-title":"EMBO Journal"},{"key":"10.1016\/j.virol.2013.10.010_bib53","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature09863","article-title":"Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection","volume":"471","author":"Wakim","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.virol.2013.10.010_bib54","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/icb.2010.161","article-title":"Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway","volume":"89","author":"Win","year":"2011","journal-title":"Immunology and Cell Biology"},{"key":"10.1016\/j.virol.2013.10.010_bib55","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1016\/j.vaccine.2006.03.052","article-title":"Transcutaneous vaccination with virus-like particles","volume":"24","author":"Young","year":"2006","journal-title":"Vaccine"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682213005709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682213005709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:22:50Z","timestamp":1758586970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682213005709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":55,"alternative-id":["S0042682213005709"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2013.10.010","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2013.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}